HeartMate 3™ LVAD Receives CE Mark Approval
Approved for use in the EU, HeartMate 3 with Full MagLev™ flow technology elevates LVAD therapy to even higher standards by offering unprecedented
MOMENTUM 3 U.S. IDE Clinical Trial
The MOMENTUM 3 U.S. IDE Clinical Trial is a prospective, multi-center, unblinded randomized study comparing the HeartMate 3 Left Ventricular Assist System (LVAS) to the HeartMate II LVAS in advanced stage heart failure patients.
Introducing a new website for healthcare professionals, featuring information and resources to open a new world for your advanced heart failure patients. Learn More
Approved for use in the EU, HeartMate PHP is an acute percutaneous heart pump with a low insertion profile that disrupts the traditional relationship between size and flow to deliver near–full physiological mean blood flow.33